Stratview Research announces the launch of a new market research report on Opportunities & Gaps in the European In Vitro Diagnostic Market - By Products & Services (Reagents & Kits, Equipment, New Technology/Connect Laboratories (AI in lab), Data Management Services, Laboratory Support Services); By Technology (Immunohistochemistry, Clinical Chemistry, Molecular Diagnostics, Urinalysis, Hematology, Microbiology, POCT, Coagulation and Others); By Therapeutic Application (Infectious Diseases, Life Style Diseases (Diabetes, Obesity, etc), Oncology, Cardiology, Nephrology, Autoimmune Disorder and Drug Testing); By End User (Hospital – Laboratories / ICU/ Care Units, Hospitals – Patient Bedside (POCT), Advanced Clinical Laboratories (Referred by physicians), Self-Tests / Walk ins, Research and Academic Laboratories, Home users/ Aged Care/ Long Term Care/Hospice/ Community Care) and By Region (European Region, Germany, France, The United Kingdom: 2018-2025
The Burning Questions This Report Will Answer:
European In Vitro Diagnostics Market (Major Focus on Germany, France and The United Kingdom)
This market report, from Stratview Research, studies the European In Vitro diagnostic market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The research report provides detailed insights on the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
As per Stratview Research, the European In Vitro Diagnostic market is poised to offer healthy growth opportunities during the forecast period of 2018 to2025. It should not come as a surprise that while the markets in Britain may face some fluctuations due to Brexit, major players in Britain are hopeful that with the new dynamics, newer opportunities will knock the doors of the UK’s IVD market. Germany shall remain the market leader followed by France at No. 2 position, followed by Italy. Among the smaller nations, Poland, Czech Republic, Romania, Ireland and United Kingdom will show more growth than the remaining European nations. The report explores the opportunities and gaps in the top two IVD market of Europe as well as the most watched IVD market in 2018-2019, i.e., the UK.
On one hand the report deals with the typology of out-of-pocket payments per country which varies in European member states which leads to varied payments by patients in different countries (impacts the cost of IVD tests) and on the other hand, it also looks at the attractive segments where IVD companies may come across decision makers and focus their marketing strategies accordingly. Infectious diseases, oncology, life style diseases shall remain the top three attractive segments in Europe.
Europe accounts for 23.4% of the global cancer cases and 20.3% of cancer deaths, although it has only 9 per cent of the global population. Europe is characterized by striking geographical differences in cancer occurrence. There were an estimated 3.5 million new cancer cases and 1.9 million cancer deaths in Europe in 2012. Cancers of the female breast, colo-rectum, prostate and lung constitute over half of the overall incidences, while lung and colorectal cancer rank as the most common causes of cancer death. It widely varies from country to country.
In men, prostate cancer is the most frequent form of cancer incidence in most Northern, Western and Southern European countries, while lung cancer is the most frequently diagnosed cancer in Central and Eastern Europe. Lung cancer is the leading cause of cancer death among men in almost all European countries, while breast cancer dominates as the most frequent one in women. Lung cancer is also a leading cause of cancer death in certain European countries among women, overtaking breast cancer.
While breast cancer incidence rates continued to increase in most European countries, mortality rates decreased, as a result of earlier diagnosis and improved therapies. IVD market is attractive and prominent among the oncologists. Besides, therapy area, the report highlights the attractiveness in products and services, end user markets.
The study looks at the major import and export IVD markets in Europe and analyses the trends from 2014 till date. It also provides country wise data i.e. import and export destinations in Germany, France and the UK from 2014, while giving insights on changing dynamics between new emerging markets for IVD companies. The report highlights the teething issues of new investors in markets such as Germany, the UK and France and guide them through the “do’s and don’ts in the market”.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 20 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
European In Vitro Diagnostics Market - Segmentation
By Products & Services
By Therapy Area
By End User
(Extra Coverage – Eastern Europe, Romania, Switzerland, Austria, Poland, The Netherlands, Sweden, Spain, Ireland for market share and import and export data)
Stratview Research has number of high value market reports in the global healthcare industry. Please refer to the following link to browse through our reports:
Click Here for Other Reports from Stratview Research in the Healthcare Industry
Our related premium market report in the healthcare industry:
Opportunities & Gaps in the In Vitro Diagnostic Testing Market: By Product (Instruments, Reagents), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, and Urinalysis, Microbiology), By Application (Diabetes, Infectious diseases, Oncology, Cardiology, Nephrology, and Other Diseases) By Type of Demand for Sample (Urine, Hair, and Oral), By Testing Facility (Hospital Laboratories, Independent Clinical Laboratories and Others), by Region (North America, Western Europe, Asia-Pacific, Latin America, Rest of the World): 2018-2025
About Stratview Research
Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.
We have a strong team of industry veterans and analysts with an extensive experience in executing custom research projects for mid-sized to Fortune 500 companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, Go to Market Strategy, and Voice of Customer studies.
Stratview Research is a trusted brand globally, providing high quality research and strategic insights that help companies worldwide in effective decision making.
E-mail: [email protected]